Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04172857
Other study ID # QZB-MG
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2015
Est. completion date January 30, 2019

Study information

Verified date November 2019
Source Wenzhou Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To compare the surgical outcomes of treating phacoemulsification with intraocular lens implantation combined with goniosynechialysis (Phaco-IOL-GSL) associated malignant glaucoma (MG), using different incision sites in anterior vitrectomy combined with hyaloidotomy, zonulectomy, and iridectomy (VHZI).


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date January 30, 2019
Est. primary completion date January 20, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- MG was diagnosed based on the presence of a central and peripheral shallow anterior chamber with normal or elevated intraocular pressure (IOP).

Exclusion Criteria:

- The diagnosis was made only after confirming the absence of choroidal detachment or hemorrhage and posterior segment mass lesion, using B-scan ultrasonography or ophthalmoscopy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
anterior vitrectomy combined with hyaloidotomy, zonulectomy and iridectomy
First, a 23-G incision was made at the peripheral inferior temporal sector of the cornea and connected with an anterior chamber infusion cannula. Another corneal incision was made at the superior temporal sector or superior nasal sector, and Viscoat® (Bausch & Lomb, Shandong, China) was infused though the incision to fill the anterior chamber. Iridotomy was performed through the incision using Wescott scissors and toothed forceps. Hyaloidectomy and zonulectomy were performed through a peripheral iris defect using an anterior chamber approach to set up a pathway between the anterior chamber and the vitreous cavity. We repeatedly carried out vitrectomy around the pathway to reduce the risk of postoperative re-obstruction of the tunnel created.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Wenzhou Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Relapse of MG MG relapse after the anterior vitrectomy combined with hyaloidotomy, zonulectomy, and iridectomy (VHZI). follow up: 3 to 31 months
See also
  Status Clinical Trial Phase
Recruiting NCT04602923 - Keratometric Change After XEN, Trabeculectomy and Tube Shunts N/A
Recruiting NCT03605823 - Pars Plana Ex-Press Shunt in Vitrectomized Eyes Phase 1/Phase 2
Not yet recruiting NCT05593354 - MicroPulse TLT - UK Study
Completed NCT03187418 - Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma N/A
Active, not recruiting NCT05451745 - Glaucoma Following Pediatric Cataract Surgery
Enrolling by invitation NCT04381611 - INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Completed NCT04215575 - Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases N/A
Completed NCT04214847 - The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases N/A
Completed NCT05446077 - Quantitatively Analysis of Fundus Structure Characteristics in Glaucoma Following Congenital Cataract Surgery
Completed NCT03800589 - Assessment of Effectiveness Ex-Press Surgery Modification N/A